As of Friday, January 23, Nektar Therapeutics’s NKTR share price has surged by 7.36%, which has investors questioning if this ...
Coya Therapeutics, Inc. (NASDAQ: COYA) ("Coya" or the "Company"), a clinical-stage biotechnology company developing biologics ...
A recent study by Vanderbilt Health researchers has revealed a greater, detrimental role for B lymphocytes (B cells) in the ...
As of Friday, January 23, Coherus Oncology, Inc.’s CHRS share price has surged by 21.70%, which has investors questioning if ...
Cohort 4 data demonstrated positive safety and efficacy results, including additional clinical benefit observed following ...
Saudi Gazette on MSN
SFDA approves registration of 'Anktiva' for treatment of bladder and lung cancer
Saudi Gazette reportRIYADH — The Saudi Food and Drug Authority (SFDA) has granted conditional approval for Anktiva (nogapendekin alfa inbakicept) in combination with immunotherapy for adult patients ...
Kairos Pharma Ltd. , a clinical-stage biopharmaceutical company focused on innovative cancer therapeutics, today announced ...
Victoria Park Medispa, one of Canada's leading medical aesthetics platforms, today announced the acquisition of PHI Medical ...
Autoimmune diseases arise when the immune system mistakenly targets and damages the body’s cells and tissues as though they ...
New immune profiling data confirms disease-modifying mechanism, reinforces earlier signals of fibrosis resolution, lung repair, and improved lung function LA JOLLA, CA, Jan. 08, 2026 (GLOBE NEWSWIRE) ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results